Health TrialsbyHealthPanel

Interscalene Block Versus Anterior Suprascapular Block for Post-Thoracotomy Shoulder Pain

ConditionsInterscalene BlockAnterior Suprascapular BlockThoracotomyShoulder Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorNational Cancer Institute, Egypt

About this trial

This study aims to compare the frequency of occurrence of ipsilateral shoulder pain in patients undergoing thoracotomy with ultrasound-guided interscalene block, anterior suprascapular block as adjunct to epidural and epidural block only.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age > 18 years and ≤ 65 years old.

American Society of Anesthesiologists (ASA) physical status II-III.

Body mass index 18-35 kg/m2.

Patients who have a confirmed diagnosis of lung cancer and are scheduled for elective open-lung surgery.

Disqualifiers

Allergy to local anesthetics.

Known psychiatric or neurologic disorders.

Alcohol or narcotics abuse.

Contraindications to thoracic epidural or suprascapular block, or interscalene block, e.g., coagulopathy or local infection.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Interscalene block

    Other intervention

    Patients will receive an ultrasound-guided interscalene block.

  • Anterior suprascapular block

    Other intervention

    Patients will receive an ultrasound-guided anterior suprascapular block.

  • Epidural analgesia

    Other intervention

    Patients will not receive regional blocks apart from epidural analgesia.

Treatment groups

75 Participants
are divided into 3 treatment groups
Group A: Group (I)Experimental treatment 1 intervention
Group B: Group (S)Experimental treatment 1 intervention
Group C: Group (E)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Frequency of occurrence of ipsilateral shoulder pain

Frequency of occurrence of ipsilateral shoulder pain will be recorded.

Time frame
72 hours postoperatively

Secondary outcomes

1

Degree of pain

Each patient will be instructed about postoperative pain assessment with the visual analog scale (VAS). VAS (0 represents "no pain" while 10 represents "the worst pain imaginable"). VAS will be recorded after intensive care unit (ICU) admission then every 6 h postoperative for 72 h.

Time frame
72 hours postoperatively
2

Mean arterial pressure

Mean arterial pressure will be recorded every 30 minutes and immediately postoperative then every 4 h postoperative for 48 h.

Time frame
48 hours postoperatively
3

Heart rate

Heart rate will be recorded every 30 minutes and immediately postoperative then every 4 h postoperative for 48 h.

Time frame
48 hours postoperatively
4

Incidence of complications

Incidence of postoperative complications will be recorded.

Time frame
72 hours postoperatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

National Cancer Institute, Egypt

Lead sponsor

Source ClinicalTrials.gov
Apply now